BIOMAT Database Logo BIOMAT Database Logo

Failure of the opiate antagonist naloxone to modify hypnotic analgesia. 1975

A Goldstein, and E R Hilgard

Hypnotic analgesia in some respects resembles opiate analgesia. We tested the hypothesis that some features of hypnotic analgesia are mediated through neuronal pathways activating specific opiate receptors in brain. The opiate antagonist naloxone had no effect on hypnotic analgesia in three subjects. Thus, the hypothesis was not confirmed.

UI MeSH Term Description Entries
D006991 Hypnosis, Anesthetic Procedure in which an individual is induced into a trance-like state to relieve pain. This procedure is frequently performed with local but not general ANESTHESIA. Hypnoanesthesia,Hypnosedation,Anesthetic Hypnoses,Anesthetic Hypnosis,Hypnoanesthesias,Hypnosedations,Hypnoses, Anesthetic
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Goldstein, and E R Hilgard
Failure of naloxone to modify the depth of hypnotic trance.
July 1983, Experientia,
A Goldstein, and E R Hilgard
Naloxone--opiate antagonist.
October 1981, Drug and therapeutics bulletin,
A Goldstein, and E R Hilgard
The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia.
March 1996, Pain,
A Goldstein, and E R Hilgard
Opiate antagonism fails to reverse hypnotic-induced analgesia.
June 1979, Lancet (London, England),
A Goldstein, and E R Hilgard
Anorectic actions of the opiate antagonist naloxone.
December 1981, Neuropharmacology,
A Goldstein, and E R Hilgard
Opiate antagonist, naloxone, strongly reduces analgesia induced by stimulation of a raphe nucleus (centralis inferior).
January 1977, Brain research,
A Goldstein, and E R Hilgard
Naloxone-induced analgesia: involvement of kappa-opiate receptors.
September 1993, Pharmacology, biochemistry, and behavior,
A Goldstein, and E R Hilgard
On the specificity of naloxone as an opiate antagonist.
November 1979, Life sciences,
A Goldstein, and E R Hilgard
Antipruritic effect of an opiate antagonist, naloxone hydrochloride.
January 1982, The Journal of investigative dermatology,
A Goldstein, and E R Hilgard
The influence of the opiate antagonist naloxone on experimental pruritus.
January 1984, Acta dermato-venereologica,
Copied contents to your clipboard!